Prosecution Insights
Last updated: October 25, 2026

M/S Ddreg Pharma Private Limited

Technology area: Transportation, E-Commerce & Mechanical Systems

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

M/S Ddreg Pharma Private Limited has 1 pending office action in its patent portfolio within the Transportation, E-Commerce & Mechanical Systems technology area. This action is assigned to 1 distinct examiner. The prosecution is taking place within 1 distinct art unit, indicating a specific technical focus for the company's current application. The involvement of 1 distinct art unit within the Transportation, E-Commerce & Mechanical Systems sector suggests a narrow technical review process.

SHORTER, RASHIDA R is the busiest examiner for the company, currently managing 1 pending office action. This 1 action accounts for the entire pending workload for M/S Ddreg Pharma Private Limited. Consequently, the company's current interactions with the patent office are focused on the review conducted by SHORTER, RASHIDA R. For practitioners, this means the prosecution strategy is tied to a single examiner and a single art unit. The 1 to 1 ratio of pending actions to examiners provides a streamlined and singular point of engagement for the company's active patent matters.

The 1 to 1 ratio of pending actions to examiners provides a streamlined prosecution path without the complexities of multi-examiner coordination. This data suggests a stable and manageable prosecution workload for the company's current intellectual property assets. For patent practitioners, this means that all current strategic responses and examiner interviews are concentrated with one specific official. This concentration allows for a highly tailored approach to prosecution, as the applicant can focus exclusively on the preferences and historical tendencies of SHORTER, RASHIDA R.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHORTER, RASHIDA R 1 17.9% +25.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18845755 SYSTEM(S) AND METHOD(S) FOR REGULATORY PRODUCT LIFECYCLE MANAGEMENT WITH REGULATORY INTELLIGENCE SHORTER, RASHIDA R —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18845755 SYSTEM(S) AND METHOD(S) FOR REGULATORY PRODUCT LIFECYCLE MANAGEMENT WITH REGULATORY INTELLIGENCE SHORTER, RASHIDA R —

Top Art Units

Art UnitApps
3626 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18845755 SYSTEM(S) AND METHOD(S) FOR REGULATORY PRODUCT LIFECYCLE MANAGEMENT WITH REGULATORY INTELLIGENCE SHORTER, RASHIDA R 3626 §101§103 Non-Final OA — Pending Sep 10, 2024

Managing M/S Ddreg Pharma Private Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does M/S Ddreg Pharma Private Limited have?

M/S Ddreg Pharma Private Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most M/S Ddreg Pharma Private Limited applications?

Rashida R Shorter has the most, with 1 of M/S Ddreg Pharma Private Limited's pending office actions.

What technology area are M/S Ddreg Pharma Private Limited's patent applications in?

Mostly Transportation, E-Commerce & Mechanical Systems (USPTO Tech Center 3600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month